Free Trial

Carlsmed (CARL) Competitors

Carlsmed logo
$13.01 -0.88 (-6.34%)
As of 04:00 PM Eastern

CARL vs. CNMD, ESTA, BLFS, KMTS, PLSE, TNDM, MDXG, IRMD, INMD, and BBNX

Should you be buying Carlsmed stock or one of its competitors? The main competitors of Carlsmed include CONMED (CNMD), Establishment Labs (ESTA), BioLife Solutions (BLFS), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), Tandem Diabetes Care (TNDM), MiMedx Group (MDXG), iRadimed (IRMD), InMode (INMD), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.

Carlsmed vs. Its Competitors

CONMED (NYSE:CNMD) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

CONMED has a net margin of 8.31% compared to Carlsmed's net margin of 0.00%. CONMED's return on equity of 14.43% beat Carlsmed's return on equity.

Company Net Margins Return on Equity Return on Assets
CONMED8.31% 14.43% 6.05%
Carlsmed N/A N/A N/A

CONMED currently has a consensus target price of $59.80, suggesting a potential upside of 24.20%. Given CONMED's stronger consensus rating and higher possible upside, equities research analysts clearly believe CONMED is more favorable than Carlsmed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Carlsmed
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

CONMED has higher revenue and earnings than Carlsmed.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CONMED$1.31B1.14$132.42M$3.5313.64
Carlsmed$27.17M12.73N/AN/AN/A

In the previous week, Carlsmed had 3 more articles in the media than CONMED. MarketBeat recorded 4 mentions for Carlsmed and 1 mentions for CONMED. CONMED's average media sentiment score of 1.54 beat Carlsmed's score of 0.00 indicating that CONMED is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CONMED
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Carlsmed
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

CONMED beats Carlsmed on 8 of the 10 factors compared between the two stocks.

Get Carlsmed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CARL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CARL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CARL vs. The Competition

MetricCarlsmedSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ Exchange
Market Cap$345.81M$182.06M$2.53B$10.67B
Dividend YieldN/AN/A2.49%4.86%
P/E RatioN/A2.0321.9228.52
Price / Sales12.734.64109.24129.07
Price / CashN/A4.0343.6061.42
Price / BookN/A1.5633.656.52
Net IncomeN/A-$51.31M$6.87M$276.75M
7 Day Performance-4.55%-2.89%0.35%0.21%
1 Month Performance-9.84%-6.95%-0.29%1.68%
1 Year PerformanceN/A292.59%94.53%32.79%

Carlsmed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CARL
Carlsmed
N/A$13.01
-6.3%
N/AN/A$345.81M$27.17M0.00100News Coverage
Positive News
Short Interest ↑
CNMD
CONMED
4.7888 of 5 stars
$45.11
+0.3%
$59.80
+32.6%
-22.5%$1.39B$1.31B12.783,900Positive News
ESTA
Establishment Labs
1.793 of 5 stars
$47.26
+1.4%
$56.50
+19.6%
+10.4%$1.35B$166.02M-15.501,018
BLFS
BioLife Solutions
2.3455 of 5 stars
$27.32
-1.5%
$31.29
+14.5%
+21.8%$1.33B$82.25M-227.65440Positive News
KMTS
Kestra Medical Technologies
0.7704 of 5 stars
$24.61
+5.8%
$27.33
+11.1%
N/A$1.20B$59.81M0.00300
PLSE
Pulse Biosciences
3.5487 of 5 stars
$17.56
-0.1%
$22.00
+25.3%
-2.2%$1.18B$700K-16.72140Upcoming Earnings
TNDM
Tandem Diabetes Care
4.1901 of 5 stars
$14.79
-3.3%
$22.19
+50.0%
-55.4%$1.03B$940.20M-4.792,650Analyst Forecast
MDXG
MiMedx Group
3.1851 of 5 stars
$6.69
+0.9%
$12.00
+79.4%
+17.5%$980.97M$348.88M31.86870News Coverage
Positive News
Upcoming Earnings
IRMD
iRadimed
4.679 of 5 stars
$73.43
-3.4%
$72.00
-1.9%
+52.3%$966.98M$73.24M45.33110News Coverage
Upcoming Earnings
Insider Trade
INMD
InMode
3.0027 of 5 stars
$15.31
+0.6%
$16.85
+10.1%
-15.0%$962.04M$394.82M6.20480
BBNX
Beta Bionics
3.2634 of 5 stars
$20.02
-3.0%
$24.44
+22.1%
N/A$896.79M$65.12M0.00294Analyst Forecast
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:CARL) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners